Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

HP Shares Face Critical Test Amid Persistent Downtrend

Robert Sasse by Robert Sasse
November 10, 2025
in Analysis, S&P 500, Tech & Software
0
HP Stock
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

HP’s stock performance continues to disappoint investors as the company struggles to reverse a significant downward trajectory. Year-to-date, the shares have declined by 15.2%, while the twelve-month performance shows an even steeper drop of nearly 30%. This weakness stands in stark contrast to broader market indicators, with the S&P 500 advancing 16.3% and the technology sector posting impressive gains of 29.3% over the same period.

Market Experts Divided on Outlook

Financial analysts remain predominantly cautious, with most maintaining “Hold” ratings on the stock. Consensus price targets range between $28.23 and $29.63, suggesting limited upside potential from current trading levels. However, beneath this apparent consensus lies significant disagreement among major financial institutions.

On October 14, HSBC upgraded HP to “Buy” with a $30 price target, citing expectations of a PC market recovery and potential benefits from Windows-10 phase-out effects. Just eight days later, JP Morgan moved in the opposite direction, downgrading from “Buy” to “Hold” despite maintaining the same $30 price objective.

Fourth Quarter Earnings Loom as Decisive Moment

All eyes turn to November 25 when HP releases its quarterly results, which will serve as a crucial test for the struggling company. The technology firm is projected to experience an 8% EPS decline for the full 2025 fiscal year. Current expectations for the fourth quarter range between $0.87 and $0.97 per share.

Should investors sell immediately? Or is it worth buying HP?

The company’s recent track record raises concerns about its ability to meet these targets. HP has missed profit forecasts in three of the last four quarterly reports. Market participants are closely monitoring the PC division’s performance and the market reception of newly introduced AI-enabled computers. Any guidance provided for fiscal year 2026 will undergo intense scrutiny.

AI Expansion Strategy Offers Glimmer of Hope

On October 13, HP announced plans to establish a new manufacturing facility and artificial intelligence research center in Saudi Arabia. The facility already produces the HP EliteDesk AI PC, representing a strategic positioning within the growing AI hardware market. The critical question remains whether this initiative can generate sufficient momentum to reverse the company’s negative trend.

Technical and Fundamental Assessment

From a technical perspective, the outlook remains pessimistic across all time horizons with a pronounced short bias. Despite the challenging technical picture, the company maintains a market capitalization of $24.20 billion and offers a dividend yield of 4.40%, which may continue to attract income-focused investors. Nevertheless, a fundamental turnaround for the equity has yet to materialize.


Disclaimer: This content is for informational purposes only and does not constitute investment advice.

Ad

HP Stock: Buy or Sell?! New HP Analysis from February 7 delivers the answer:

The latest HP figures speak for themselves: Urgent action needed for HP investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

HP: Buy or sell? Read more here...

Tags: HP
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Diginex Stock
Blockchain

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Hydrofarm Holdings Inc Stock
Analysis

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Next Post
Humana Stock

Humana Shares Plunge Following Earnings Forecast Slash

Jamf Holding Stock

Jamf Faces Pivotal Moment as Earnings and Acquisition Converge

Tilray Stock

Tilray Shares Navigate Turbulent Waters Amid Mixed Signals

Recommended

Dare Bioscience Stock

Dare Bioscience Stock: Analysts Project Triple-Digit Upside Potential

4 months ago
Bloom Energy Stock

Fuel Cell Leader Bloom Energy Capitalizes on AI Infrastructure Demand

3 months ago
AI travel

NextTrip Inc Announces Official Transition and Ticker Symbol Change

2 years ago
Genprex Stock

Genprex Shares Plunge Amid Heavy Selling Pressure

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Coherus BioSciences Forges Key Oncology Alliance with Janssen

Trending

Camping World Stock
Consumer & Luxury

Camping World’s New Leadership Faces First Major Test

by Jackson Burston
February 7, 2026
0

All eyes are on Camping World Holdings as it approaches a pivotal quarterly report. This will be...

Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026
Diginex Stock

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Deluxe Stock

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Hydrofarm Holdings Inc Stock

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Camping World’s New Leadership Faces First Major Test
  • Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment
  • Diginex Enters Critical Implementation Phase Following Strategic Moves

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com